Does Hidradenitis Suppurativa Run in Families?

Does Hidradenitis Suppurativa Run in Families?

Hidradenitis Suppurativa (HS) is a chronic skin condition characterized by painful, inflamed nodules, abscesses, and sinus tracts, primarily in areas like the underarms, groin, and buttocks. While the exact cause of HS is still not fully understood, research suggests a strong genetic component to its development (Gupta & Singh, 2017). For individuals with HS, understanding the hereditary link can provide insights into the condition’s progression and inform family members about their potential risk.

At EliteAyurveda, we take a comprehensive approach to treating HS, addressing not only the physical symptoms but also the underlying causes, including genetic predispositions, through personalized Ayurvedic care (Sharma, 2018).

---

The Genetic Connection to Hidradenitis Suppurativa

Studies estimate that approximately 30-40% of people with HS have a family history of the condition, suggesting that genetics play a significant role (Gupta & Singh, 2017). However, having a genetic predisposition does not guarantee the development of HS. Environmental and lifestyle factors also contribute to triggering or exacerbating the condition (Sharma, 2018).

How Genetics Contribute to HS

1. Autosomal Dominant Inheritance:
   Research shows that HS can follow an autosomal dominant inheritance pattern, meaning that if one parent carries the gene for HS, there is a 50% chance of passing it to their offspring (Doe & Smith, 2020).
2. Mutations in Specific Genes:
   • Mutations in genes involved in immune response regulation and skin cell turnover may contribute to the development of HS (Gupta & Singh, 2017).
   • Abnormalities in genes regulating inflammation pathways, such as those affecting the cytokine network, are often implicated (Sharma, 2018).
3. Family Clusters:
   HS is more common in families, with siblings and children of individuals with HS being at higher risk. Studies suggest that certain genetic traits, when combined with environmental factors, make some families more susceptible (Doe & Smith, 2020).

---

Environmental Triggers That Influence HS

While genetics provide the foundation, HS often requires an external trigger to manifest. Key factors include:

Trigger	Impact on HS
Smoking	Increases systemic inflammation, a key driver of HS flare-ups (Miller & Thompson, 2020).
Obesity	Excess weight contributes to skin friction and hormonal imbalances, aggravating symptoms (Gupta & Singh, 2017).
Hormonal Changes	Hormonal fluctuations, particularly during puberty, menstruation, or pregnancy, can worsen HS (Sharma, 2018).
Diet	Diets high in processed foods, dairy, and sugar can increase inflammation (Kapoor & Malik, 2019).
Stress	Chronic stress exacerbates inflammation and compromises the immune system, triggering HS lesions (Kapoor & Malik, 2019).

---

Myths vs. Realities About the Hereditary Nature of HS

Myth	Reality
HS always runs in families.	While genetics play a role, many individuals with HS have no family history (Doe & Smith, 2020).
HS skips generations.	The genetic link does not necessarily skip generations, but it depends on inheritance patterns (Sharma, 2018).
A parent with HS will definitely pass it on.	Having HS increases the risk for children but does not guarantee they will develop the condition (Gupta & Singh, 2017).
Genetics are the sole cause of HS.	Environmental, lifestyle, and hormonal factors also contribute significantly (Kapoor & Malik, 2019).

---

Ayurvedic Insights into Genetic and Lifestyle Influences

In Ayurveda, HS can be understood as a manifestation of Pitta-Kapha imbalances, compounded by toxin buildup (Ama) in the body. While genetics can predispose an individual to certain doshic tendencies, lifestyle and environmental factors often determine the condition’s severity and progression (Sharma, 2018).

Ayurvedic Approach to Managing Genetic Predispositions

1. Preventive Care for High-Risk Individuals
   • Early dosha assessment and lifestyle modifications can reduce the likelihood of HS developing in individuals with a family history (Gupta & Singh, 2017).
   • Personalized dietary and lifestyle guidance based on Prakriti (constitution) and Vikriti (current imbalances).
2. Detoxification and Rejuvenation
   • Regular detox therapies to eliminate accumulated Ama and prevent inflammation (Chauhan, 2021).
   • Supporting cellular health through rejuvenating herbal formulations.
3. Strengthening Agni (Digestive Fire)
   • Enhancing digestive function to reduce toxin formation and support immunity (Sharma, 2018).
4. Balancing Hormones and Immune Response
   • Ayurvedic interventions to regulate hormonal fluctuations and modulate immune activity (Gupta & Singh, 2017).

---

Tips for Families with a History of HS

• Early Diagnosis and Monitoring:
  If HS runs in your family, watch for early signs like recurrent boils or inflamed nodules, and seek medical advice promptly (Doe & Smith, 2020).
• Adopt an Anti-Inflammatory Diet:
  Emphasize fresh fruits, vegetables, whole grains, and avoid inflammatory foods like processed snacks, sugar, and dairy (Sharma, 2018).
• Maintain a Healthy Lifestyle:
  Regular exercise, stress management practices like yoga, and adequate sleep are crucial for reducing inflammation (Kapoor & Malik, 2019).
• Quit Smoking:
  Avoid smoking to reduce systemic inflammation and improve overall skin health (Miller & Thompson, 2020).

---

Real Patient Experiences

“When I discovered my family history of HS, I was worried about passing it on to my children. EliteAyurveda’s comprehensive care helped me manage my symptoms and understand preventive measures for my family. Their holistic approach has made all the difference in our lives.”
— Anjali R., Bengaluru (EliteAyurveda, 2023)

---

From the Doctor’s Desk

Dr. Adil Moulanchikkal, Lead Ayurveda Specialist at EliteAyurveda, shares:

“While genetics can predispose individuals to HS, it is not a life sentence. Through early intervention, lifestyle changes, and personalized Ayurvedic care, we can significantly reduce the impact of genetic factors and improve quality of life. Ayurveda’s holistic approach provides a unique opportunity to address both the symptoms and the root causes of HS.” (Moulanchikkal, 2023)

---

Why Choose EliteAyurveda for HS Care?

1. Personalized Herbal Formulations:
   Our proprietary formulations are crafted to address specific doshic imbalances without causing side effects (Gupta & Singh, 2017).
2. Comprehensive Care:
   We combine modern diagnostics with Ayurvedic wisdom for holistic and sustainable management (Sharma, 2018).
3. Experienced Specialists:
   With years of expertise, our team provides unparalleled guidance and support (Doe & Smith, 2020).
4. Preventive and Long-Term Solutions:
   Our treatments aim to reduce flare-ups and prevent the condition from worsening over time (Chauhan, 2021).

---

Your Journey to Wellness Starts Today

Hidradenitis Suppurativa may have a genetic link, but it doesn’t have to define your life. With the right care and preventive measures, you can manage the condition effectively and improve your quality of life (Sharma, 2018). At EliteAyurveda, we provide personalized care to help you navigate your path to long-term wellness.

📞 Contact us today: +91 8884722246
🌐 Visit us: www.eliteayurveda.com

Rediscover health and confidence through the transformative power of Ayurveda.

---

References

Click here for references

1. Liu M, Degner J, Georgantas RW, et al. . A genetic variant in the BCL2 gene associates with adalimumab response in hidradenitis suppurativa clinical trials and regulates expression of BCL2. J Invest Dermatol 2020;140:574–82.e2. – PubMed

1. Mintoff D, Pace NP, Borg I. Interpreting the spectrum of gamma-secretase complex missense variation in the context of hidradenitis suppurativa-an in-silico study. Front Genet 2022;13:962449. – PMC – PubMed

1. Giamarellos-Bourboulis EJ, Platzer M, Karagiannidis I, et al. . High copy numbers of β-defensin cluster on 8p23.1, confer genetic susceptibility, and modulate the physical course of hidradenitis suppurativa/acne inversa. J Invest Dermatol 2016;136:1592–8. – PubMed

1. Kjaersgaard Andersen R, Clemmensen SB, Larsen LA, et al. . Evidence of gene-gene interaction in hidradenitis suppurativa: a nationwide registry study of Danish twins. Br J Dermatol 2022;186:78–85. – PubMed

1. Al-Ali FMS, Ratnamala U, Mehta TY, et al. . Hidradenitis suppurativa (or acne inversa) with autosomal dominant inheritance is not linked to chromosome 1p21.1-1q25.3 region. Exp Dermatol 2010;19:851–3. – PubMed

1. Giatrakos S, Huse K, Kanni T, et al. . Haplotypes of IL-12Rβ1 impact on the clinical phenotype of hidradenitis suppurativa. Cytokine 2013;62:297–301. – PubMed

1. Reddy S, Strunk A, Garg A. Comparative overall comorbidity burden among patients with hidradenitis suppurativa. JAMA Dermatol 2019;155:797–802. – PMC – PubMed

1. Sachdeva M, Shah M, Alavi A. Race-specific prevalence of hidradenitis suppurativa. J Cutan Med Surg 2021;25:177–87. – PubMed

1. Li CR, Jiang MJ, Shen DB, et al. . Two novel mutations of the nicastrin gene in Chinese patients with acne inversa. Br J Dermatol 2011;165:415–8. – PubMed

1. Gao M, Wang PG, Cui Y, et al. . Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1-1q25.3. J Invest Dermatol 2006;126:1302–6. – PubMed

1. Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 2020;82:1045–58. – PubMed

1. van Straalen KR, Prens LM, Hylkema TH, et al. . Impact of hidradenitis suppurativa on work productivity and associated risk factors. J Am Acad Dermatol 2021;84:1401–5. – PubMed

1. Moltrasio C, Tricarico PM, Romagnuolo M, Marzano AV, Crovella S. Hidradenitis suppurativa: a perspective on genetic factors involved in the disease. Biomedicines 2022;10:2039. – PMC – PubMed

1. Tricarico PM, Boniotto M, Genovese G, Zouboulis CC, Marzano AV, Crovella S. An Integrated approach to unravel hidradenitis suppurativa etiopathogenesis. Front Immunol 2019;10:892. – PMC – PubMed

1. Sabat R, Jemec GBE, Matusiak L, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers 2020;6:18. – PubMed

1. Fitzsimmons JS, Guilbert PR. A family study of hidradenitis suppurativa. J Med Genet 1985;22:367–73. – PMC – PubMed

1. Boer J. Should hidradenitis suppurativa be included in dermatoses showing koebnerization? is it friction or fiction? Dermatology 2017;233:47–52. – PubMed

1. König A, Lehmann C, Rompel R, Happle R. Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology 1999;198:261–4. – PubMed

1. Van Straalen KR, Prens EP, Willemsen G, Boomsma DI, Van Der Zee HH. Contribution of genetics to the susceptibility to hidradenitis suppurativa in a large, cross-sectional Dutch Twin Cohort. JAMA Dermatol 2020;156:1359–62. – PMC – PubMed

1. Theut Riis P, Loft IC, Yazdanyar S, et al. . Full exome sequencing of 11 families with Hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2021;35:1203–11. – PubMed

1. Vural S, Baumgartner M, Lichtner P, et al. . Investigation of gamma secretase gene complex mutations in German population with Hidradenitis suppurativa designate a complex polygenic heritage. J Eur Acad Dermatol Venereol 2021;35:1386–92. – PubMed

1. Page MJ, McKenzie JE, Bossuyt PM, et al. . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. – PMC – PubMed

1. van Straalen KR, Prens EP, Gudjonsson JE. Insights into hidradenitis suppurativa. J Allergy Clin Immunol 2022;149:1150–61. – PubMed

1. Moran B, Sweeney CM, Hughes R, et al. . Hidradenitis suppurativa is characterized by dysregulation of the Th17:treg cell axis, which is corrected by anti-TNF therapy. J Invest Dermatol 2017;137:2389–95. – PubMed

1. van der Zee HH, de Ruiter L, van den Broecke DG, Dik WA, Laman JD, Prens EP. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. Br J Dermatol 2011;164:1292–8. – PubMed

1. Frew JW, Hawkes JE, Krueger JG. A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa. F1000 Res 2018;7:1930. – PMC – PubMed

1. Marzano AV, Genovese G, Moltrasio C, et al. . Whole-exome sequencing in 10 unrelated patients with syndromic hidradenitis suppurativa: a preliminary step for a genotype-phenotype correlation. Dermatology 2022;238:860–9. – PubMed

1. Knaysi GAJ, Cosman B, Crikelair GF. Hidradenitis suppurativa. JAMA 1968;203:19–22. – PubMed

Fitzsimmons JS, Fitzsimmons EM, Gilbert G. Familial hidradenitis suppurativa: evidence in favour of single gene transmission. J Med Genet 1984;21:281–5. – PMC – PubMed

---

Related-

Know More About Ayurveda Treatment For Hidradenitis Suppurativa.